BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 34308845)

  • 1. [Macrophage migration inhibitory factor meditates MPP+/MPTP-induced NLRP3 inflammasome activation in microglia cells].
    Huang H; Gao Y; Nie K; Wang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):972-979. PubMed ID: 34308845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 Inhibits MPP
    Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model.
    Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM
    Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting microglial NLRP3 in the SNc region as a promising disease-modifying therapy for Parkinson's disease.
    Qiao C; Dang T; Zhou Y; Zhou YZ; Zhao R; Wang M
    Brain Behav; 2022 Nov; 12(11):e2784. PubMed ID: 36199191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treadmill exercise alleviates neuronal damage by suppressing NLRP3 inflammasome and microglial activation in the MPTP mouse model of Parkinson's disease.
    Wang W; Lv Z; Gao J; Liu M; Wang Y; Tang C; Xiang J
    Brain Res Bull; 2021 Sep; 174():349-358. PubMed ID: 34224819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease.
    Qiao C; Zhang Q; Jiang Q; Zhang T; Chen M; Fan Y; Ding J; Lu M; Hu G
    J Neuroinflammation; 2018 Jul; 15(1):193. PubMed ID: 29966531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
    Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
    J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
    Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
    Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation.
    Zhu H; Xiao F; Xiao Y; Guo Y; Shan X; Zhang Z; Zhang L; Guo H
    J Neuroinflammation; 2023 Dec; 20(1):304. PubMed ID: 38110963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.
    Javed H; Thangavel R; Selvakumar GP; Dubova I; Schwartz N; Ahmed ME; Zaheer S; Kempuraj D; Iyer S; Zaheer A; Khan MM
    Int Immunopharmacol; 2020 Jun; 83():106441. PubMed ID: 32259702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
    Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
    J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease.
    Chen L; Xue L; Zheng J; Tian X; Zhang Y; Tong Q
    Behav Brain Res; 2019 Jan; 356():483-489. PubMed ID: 29885849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperoside suppresses NLRP3 inflammasome in Parkinson's disease via Pituitary Adenylate Cyclase-Activating Polypeptide.
    Wang K; Lu C; Wang T; Qiao C; Lu L; Wu D; Lu M; Chen R; Fan L; Tang J
    Neurochem Int; 2022 Jan; 152():105254. PubMed ID: 34883151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.
    Cheng J; Liao Y; Dong Y; Hu H; Yang N; Kong X; Li S; Li X; Guo J; Qin L; Yu J; Ma C; Li J; Li M; Tang B; Yuan Z
    Autophagy; 2020 Dec; 16(12):2193-2205. PubMed ID: 32003282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of human umbilical cord mesenchymal stromal cells in PD mice via centrally and peripherally suppressing NLRP3 inflammasome-mediated inflammatory responses.
    Zhou L; Wang X; Wang X; An J; Zheng X; Han D; Chen Z
    Biomed Pharmacother; 2022 Sep; 153():113535. PubMed ID: 36076517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.
    Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y
    J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation.
    Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z
    Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.
    Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B
    Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.